|
|
 |
|
Viewing report
|
|
|
|
Analytical Tool - Angiogenesis in Oncology
Bioseeker, Jan 2009
'Analytical Tool - Angiogenesis in Oncology' offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in anti-angiogenic drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.
Included in this advantageous package are two products already appreciated by many of our customers:
Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
Angiogenesis in Oncology: Drug Pipeline Update 2009*
The Package Includes
- A progress analysis on current and emerging drugs
- Information on most companies active in anti-angiogenic R&D in oncology
- Information on key industry related anti-angiogenic drug projects in oncology
- Data from most important clinical trials
- Information on early developmental stage projects
- Possibility of performing advanced searches suited to your individual needs
This Tool will Assist You in:
- Tracking cutting edge companies, therapies and new technologies
- Rapid identification of partners & competitors
- Laying down a comprehensive framework for further analysis of the field
- Producing presentations surrounding the development of anti-angiogenic drugs in oncology
- Identifying emerging anti-angiogenic cancer products & key areas of pharmaceutical R&D
* Our CD-ROM searchable database reflects the most recent advances in the field of anti-angiogenic drug development for the treatment of cancer, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with our CD-ROM searchable databases is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, our CD-ROM searchable databases give better overview and specific search capabilities.
Customers who bought this item also bought
Analytical Tool - Competitive Outlook on Anti-Angiogenesis and Vascular Targeting in Oncology
Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
Analytical Tool - Apoptosis in Oncology
Analytical Tool - Protein Kinase Inhibitors in Oncology 2009
Analytical Tool - Competitive Outlook on Apoptosis in Oncology
Analytical Tool - Cancer Vaccines
Analytical Tool - Breast Cancer
Analytical Tool - Prostate Cancer
Analytical Tool - Competitive Outlook on Cancer Vaccines
Triple Analysis: Apoptosis Agents, Protein Kinase Inhibitors and Anti-Angiogenic Agents in Oncology
Analytical Tool - Breast Cancer Therapeutics & Competitive Insights
Analytical Tool - Prostate Cancer: A Therapeutic & Competitive Insight
|
|
|
|
